Skip to main content
Top
Published in: Acta Neuropathologica 2/2020

01-02-2020 | Brain Tumor | Original Paper

Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults

Authors: Christian Thomas, Annika Wefers, Susanne Bens, Karolina Nemes, Abbas Agaimy, Florian Oyen, Silke Vogelgesang, Fausto J. Rodriguez, Francesca M. Brett, Roger McLendon, Istvan Bodi, Fanny Burel-Vandenbos, Kathy Keyvani, Stefan Tippelt, Frantz R. Poulsen, Eric S. Lipp, Caterina Giannini, Guido Reifenberger, Klaus Kuchelmeister, Torsten Pietsch, Uwe Kordes, Reiner Siebert, Michael C. Frühwald, Pascal D. Johann, Martin Sill, Marcel Kool, Andreas von Deimling, Werner Paulus, Martin Hasselblatt

Published in: Acta Neuropathologica | Issue 2/2020

Login to get access

Abstract

Atypical teratoid/rhabdoid tumor (ATRT) is a highly malignant brain tumor predominantly occurring in infants. Mutations of the SMARCB1 gene are the characteristic genetic lesion. SMARCB1-mutant tumors in adolescents and adults are rare and may show uncommon histopathological and clinical features. Here we report seven SMARCB1-deficient intracranial tumors sharing distinct clinical, histopathological and molecular features. Median age of the four females and three males was 40 years (range 15–61 years). All tumors were located in the pineal region. Histopathologically, these tumors displayed spindled and epithelioid cells embedded in a desmoplastic stroma alternating with a variable extent of a loose myxoid matrix. All cases showed loss of nuclear SMARCB1/INI1 protein expression, expression of EMA and CD34 was frequent and the Ki67/MIB1 proliferation index was low in the majority of cases (median 3%). Three cases displayed heterozygous SMARCB1 deletions and two cases a homozygous SMARCB1 deletion. On sequencing, one tumor showed a 2 bp deletion in exon 4 (c.369_370del) and one a short duplication in exon 3 (c.237_276dup) both resulting in frameshift mutations. Most DNA methylation profiles were not classifiable using the Heidelberg Brain Tumor Classifier (version v11b4). By unsupervised t-SNE analysis and hierarchical clustering analysis, however, all tumors grouped closely together and showed similarities with ATRT-MYC. After a median observation period of 48 months, three patients were alive with stable disease, whereas one patient experienced tumor progression and three patients had succumbed to disease. In conclusion, our series represents an entity with distinct clinical, histopathological and molecular features showing epigenetic similarities with ATRT-MYC. We propose the designation desmoplastic myxoid tumor (DMT), SMARCB1-mutant, for these tumors.
Appendix
Available only for authorised users
Literature
5.
15.
go back to reference Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA (2004) Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28:644–650CrossRefPubMed Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA (2004) Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28:644–650CrossRefPubMed
Metadata
Title
Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults
Authors
Christian Thomas
Annika Wefers
Susanne Bens
Karolina Nemes
Abbas Agaimy
Florian Oyen
Silke Vogelgesang
Fausto J. Rodriguez
Francesca M. Brett
Roger McLendon
Istvan Bodi
Fanny Burel-Vandenbos
Kathy Keyvani
Stefan Tippelt
Frantz R. Poulsen
Eric S. Lipp
Caterina Giannini
Guido Reifenberger
Klaus Kuchelmeister
Torsten Pietsch
Uwe Kordes
Reiner Siebert
Michael C. Frühwald
Pascal D. Johann
Martin Sill
Marcel Kool
Andreas von Deimling
Werner Paulus
Martin Hasselblatt
Publication date
01-02-2020
Publisher
Springer Berlin Heidelberg
Keyword
Brain Tumor
Published in
Acta Neuropathologica / Issue 2/2020
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-019-02094-w

Other articles of this Issue 2/2020

Acta Neuropathologica 2/2020 Go to the issue